-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 16, 2022, Shanghai Kaibao issued an announcement stating that the company's product Tanreqing injection was listed as recommended for severe and critical patients during the clinical treatment period (confirmed cases) in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" Medication
The company's Tanreqing injection is mainly used for the treatment of acute and chronic bronchitis, pneumonia and upper respiratory tract infections caused by bacteria or viruses